Germany
About Merck KGaA
Merck KGaA is a leading science and technology company headquartered in Darmstadt, Germany. Founded in 1668, it operates globally through three key segments: Life Science, Healthcare, and Electronics.
Business Segments
-
Life Science: Provides tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers. This segment includes:
- Process development expertise and technologies (e.g., continuous bioprocessing)
- Testing kits, reagents, and services
- Environmental testing solutions for air, water, and soil
- Nutritional and quality testing products
-
Healthcare: Focuses on discovering, developing, and marketing prescription drugs and biopharmaceuticals for:
- Oncology, neurology, immunology, and fertility
- Endocrinology, cardiovascular, diabetes, and thyroid disorders
- Multiple sclerosis and general medicines
- Injection devices and disease monitoring software
-
Electronics: Supplies materials for semiconductor and display industries, including:
- Delivery systems and services
- Surface solutions (e.g., cosmetics, effect pigments, functional applications)
Strategic Collaborations
Merck KGaA has key partnerships with:
- Debiopharm International SA: Developing drug candidates for head and neck cancer.
- Jiangsu Hengrui Pharmaceuticals Co. Ltd.: Focused on metastatic colorectal cancer treatments.
- Abbisko Therapeutics Co. Ltd.: Targeting tenosynovial giant cell tumor therapies.
- Additional collaborations for oncogenic protein degraders.
As a subsidiary of E. Merck KGaA, the company continues to drive innovation across its diversified portfolio.
